Clinical Trial Update: Evaluation of the Effect of AVE0657 on Obstructive Sleep Apnea [Phase 2]

View source ↗

Summary

Phase 2 study evaluating AVE0657 for obstructive sleep apnea has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obstructive Sleep Apnea

Drugs mentioned

• AVE0657

Snippet

Sponsor: Sanofi | Conditions: Sleep Apnea, Obstructive | Phase 2 | Status: COMPLETED